Total Payments
$6,630
2024 Payments
$1,385
Companies
32
Transactions
207
Medicare Patients
1,440
Medicare Billing
$151,764
Payment Breakdown by Category
Food & Beverage$4,302 (64.9%)
Travel$2,139 (32.3%)
Education$79.80 (1.2%)
Gifts$59.40 (0.9%)
Other$49.95 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,302 | 195 | 64.9% |
| Travel and Lodging | $2,139 | 9 | 32.3% |
| Education | $79.80 | 1 | 1.2% |
| Gift | $59.40 | 1 | 0.9% |
| Long term medical supply or device loan | $49.95 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $3,050 | 31 | $0 (2024) |
| Novo Nordisk Inc | $597.10 | 45 | $0 (2024) |
| Amgen Inc. | $332.00 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $295.45 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $275.79 | 16 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $258.88 | 10 | $0 (2024) |
| Radius Health, Inc. | $226.07 | 8 | $0 (2024) |
| Abbott Laboratories | $171.24 | 7 | $0 (2024) |
| MannKind Corporation | $154.76 | 5 | $0 (2023) |
| Merck Sharp & Dohme LLC | $154.53 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,385 | 58 | Amgen Inc. ($162.62) |
| 2023 | $951.58 | 52 | Novo Nordisk Inc ($212.78) |
| 2022 | $4,006 | 86 | Medtronic, Inc. ($3,027) |
| 2021 | $147.55 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($69.81) |
| 2020 | $121.83 | 1 | Amgen Inc. ($121.83) |
| 2018 | $18.46 | 1 | Lilly USA, LLC ($18.46) |
All Payment Transactions
207 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Radius Health, Inc. | Tymlos (Drug) | Education | In-kind items and services | $79.80 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $15.35 | General |
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Cardiology | ||||||
| 11/26/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: VACCINES | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Cardio-renal | ||||||
| 11/17/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/15/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Bone Health | ||||||
| 11/12/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/07/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: HEMATOLOGY | ||||||
| 11/04/2024 | Davol Inc. | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Surgery | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Cardio-renal | ||||||
| 10/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/24/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/18/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: DIABETES | ||||||
| 10/01/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: INFECTIOUS DISEASES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 752 | 1,128 | $290,378 | $77,798 |
| 2022 | 8 | 511 | 671 | $270,354 | $54,745 |
| 2021 | 6 | 177 | 187 | $75,798 | $19,221 |
Total Patients
1,440
Total Services
1,986
Medicare Billing
$151,764
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 178 | 339 | $116,990 | $37,035 | 31.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 119 | 189 | $66,495 | $13,914 | 20.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 82 | 82 | $36,327 | $9,656 | 26.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 74 | 147 | $17,464 | $4,355 | 24.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 61 | 81 | $20,094 | $4,061 | 20.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $12,910 | $3,172 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 47 | $11,556 | $3,069 | 26.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 79 | 114 | $1,986 | $957.60 | 48.2% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2023 | 13 | 14 | $3,291 | $937.72 | 28.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 42 | 49 | $2,542 | $466.48 | 18.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 19 | 23 | $723.17 | $175.03 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 174 | $79,745 | $18,601 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 118 | 118 | $69,207 | $13,777 | 19.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 116 | 161 | $73,496 | $12,897 | 17.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 56 | 56 | $22,217 | $4,290 | 19.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 35 | 43 | $13,910 | $2,414 | 17.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 26 | 43 | $5,109 | $1,342 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 19 | $6,157 | $1,255 | 20.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 43 | 57 | $513.00 | $169.20 | 33.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 58 | 58 | $34,101 | $8,536 | 25.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 36 | 38 | $17,486 | $4,342 | 24.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 31 | $14,250 | $3,638 | 25.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 23 | 23 | $9,146 | $2,433 | 26.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 21 | 24 | $699.12 | $233.04 | 33.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 12 | 13 | $117.00 | $39.00 | 33.3% |
About Daniel Kaplan
Daniel Kaplan is a Endocrinology, Diabetes & Metabolism healthcare provider based in San Leandro, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2016. The National Provider Identifier (NPI) number assigned to this provider is 1225491632.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Kaplan has received a total of $6,630 in payments from pharmaceutical and medical device companies, with $1,385 received in 2024. These payments were reported across 207 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,302).
As a Medicare-enrolled provider, Kaplan has provided services to 1,440 Medicare beneficiaries, totaling 1,986 services with total Medicare billing of $151,764. Data is available for 3 years (2021–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Student in an Organized Health Care Education/Training Program
- Location San Leandro, CA
- Active Since 04/01/2016
- Last Updated 03/09/2022
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1225491632
Products in Payments
- MINIMED 770G (Device) $2,835
- Rybelsus (Drug) $319.52
- JARDIANCE (Drug) $297.47
- Ozempic (Drug) $277.58
- Kerendia (Drug) $258.88
- FARXIGA (Drug) $216.40
- Repatha (Biological) $169.87
- AFREZZA (Drug) $154.76
- Dexcom G6 Transmitter (Medical Supply) $143.88
- Tymlos (Drug) $113.24
- GUARDIAN SENSOR (3) (Device) $111.79
- KEYTRUDA (Biological) $110.79
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $80.01
- FREESTYLE LIBRE 2 (Device) $79.60
- SYNTHROID (Drug) $78.61
- PREVNAR 20 (Biological) $71.37
- Otezla (Drug) $66.23
- TZIELD (Biological) $61.78
- IMBRUVICA (Drug) $60.02
- Crysvita (Drug) $56.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.